Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University of Pittsburgh
Incyte Corporation
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd
Xencor, Inc.
Incyte Corporation
AIO-Studien-gGmbH
ExcellaBio LLC
National University Hospital, Singapore